Zoladex 3.6 Mg Pre-Filled Syringe

Zoladex 3.6 mg Pre-Filled Syringe: Advanced Hormone Therapy

Zoladex 3.6 mg is a specialized pharmaceutical product designed for the continuous release of goserelin, a synthetic analogue of luteinizing hormone-releasing hormone (LHRH). This potent medication is delivered as a subcutaneous implant via a pre-filled syringe, ensuring precise and controlled administration. It is a cornerstone in the management of various hormone-sensitive conditions, operating by down-regulating LHRH receptors in the pituitary gland, thereby suppressing the production of sex hormones (testosterone in males and estrogen in females).

Benefits of Use

• Effective in treating hormone-dependent prostate cancer, helping to control disease progression and alleviate symptoms.
• Used as an adjuvant therapy in early breast cancer for pre- and perimenopausal women, reducing recurrence risk.
• Provides relief from pain and other symptoms associated with endometriosis by suppressing ovarian function.
• Helps reduce the size of uterine fibroids and manage related symptoms, often used pre-operatively.
• Offers a convenient once-every-28-days administration, reducing the burden of daily medication.

How to Use

1. Zoladex 3.6 mg must be administered by a healthcare professional. It is not intended for self-administration.
2. The implant is inserted subcutaneously into the anterior abdominal wall below the navel, with sterile technique.
3. Ensure the skin is clean and dry before administration.
4. The dose is typically one 3.6 mg implant administered every 28 days (approximately every four weeks).
5. Adhere strictly to the prescribed dosing schedule for optimal therapeutic effect.
6. Consult your doctor or pharmacist if you have any questions regarding the administration or your treatment plan.

Caution & Warnings

• Prescription Only: This medication is for prescription use only and should be used under strict medical supervision.
• Pregnancy and Lactation: Zoladex is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant.
• Side Effects: Common side effects include hot flashes, sweating, decreased libido, changes in mood, bone density loss, and injection site reactions. Report any severe or persistent side effects to your healthcare provider.
• Bone Density: Long-term use may lead to a decrease in bone mineral density. Your doctor may recommend bone density monitoring and supplementary calcium/vitamin D.
• Cardiovascular Risk: Patients with a history of cardiovascular disease or risk factors should be monitored.
• Diabetic Patients: Blood glucose levels should be monitored in diabetic patients as Zoladex may affect glucose metabolism.
• Tumor Flare (Prostate Cancer): In initial stages of prostate cancer treatment, a temporary flare of symptoms or spinal cord compression may occur.
• Driving and Operating Machinery: Patients should be aware of potential side effects that could impair their ability to drive or operate machinery safely.

Ingredients

Each pre-filled syringe contains:
Active Ingredient: Goserelin (as acetate) 3.6 mg
Excipients: A biodegradable co-polymer of lactic acid and glycolic acid.

Product Details

Brand: Zoladex
Manufacturer: AstraZeneca
Strength: 3.6 mg
Form: Subcutaneous Implant in a Pre-filled Syringe
Administration Route: Subcutaneous
Package Size: Box containing 1 pre-filled syringe with 1 implant
Storage: Store below 25°C. Do not refrigerate or freeze. Keep in original package.